These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9189765

  • 1. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.
    Parney IF, Petruk KC, Zhang C, Farr-Jones M, Sykes DB, Chang LJ.
    Hum Gene Ther; 1997 Jun 10; 8(9):1073-85. PubMed ID: 9189765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human brain tumor cell culture characterization after immunostimulatory gene transfer.
    Parney IF, Farr-Jones MA, Koshal A, Chang LJ, Petruk KC.
    Neurosurgery; 2002 May 10; 50(5):1094-102. PubMed ID: 11950413
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy for human nasopharyngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model.
    Ren SP, Wang L, Wang H, Wu B, Han Y, Wang LS, Wu CT.
    Cancer Biother Radiopharm; 2008 Oct 10; 23(5):591-602. PubMed ID: 18999931
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH, Chen Y, Chang CJ, Tai KF, Lin SM, Hwang LH.
    Clin Cancer Res; 2005 Feb 15; 11(4):1639-49. PubMed ID: 15746069
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.
    Wallenfriedman MA, Conrad JA, DelaBarre L, Graupman PC, Lee G, Garwood M, Gregerson DS, Jean WC, Hall WA, Low WC.
    J Neurosurg; 1999 Jun 15; 90(6):1064-71. PubMed ID: 10350253
    [Abstract] [Full Text] [Related]

  • 9. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
    Kojima T, Yamazaki K, Tamura Y, Ogura S, Tani K, Konishi J, Shinagawa N, Kinoshita I, Hizawa N, Yamaguchi E, Dosaka-Akita H, Nishimura M.
    Hum Gene Ther; 2003 May 20; 14(8):715-28. PubMed ID: 12804136
    [Abstract] [Full Text] [Related]

  • 10. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
    Dunussi-Joannopoulos K, Dranoff G, Weinstein HJ, Ferrara JL, Bierer BE, Croop JM.
    Blood; 1998 Jan 01; 91(1):222-30. PubMed ID: 9414288
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
    Herrlinger U, Jacobs A, Quinones A, Woiciechowsky C, Sena-Esteves M, Rainov NG, Fraefel C, Breakefield XO.
    Hum Gene Ther; 2000 Jul 01; 11(10):1429-38. PubMed ID: 10910140
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J, Ma L, Wei L.
    Chin Med J (Engl); 2001 Feb 01; 114(2):147-51. PubMed ID: 11780195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regression of established mouse leukemia by GM-CSF-transduced tumor vaccine: implications for cytotoxic T lymphocyte responses and tumor burdens.
    Hsieh CL, Pang VF, Chen DS, Hwang LH.
    Hum Gene Ther; 1997 Nov 01; 8(16):1843-54. PubMed ID: 9382951
    [Abstract] [Full Text] [Related]

  • 16. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
    Inoue H, Iga M, Nabeta H, Yokoo T, Suehiro Y, Okano S, Inoue M, Kinoh H, Katagiri T, Takayama K, Yonemitsu Y, Hasegawa M, Nakamura Y, Nakanishi Y, Tani K.
    Cancer Sci; 2008 Nov 01; 99(11):2315-26. PubMed ID: 18957055
    [Abstract] [Full Text] [Related]

  • 17. Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.
    Feng S, Han S, Pan D, Liu M, Feng X, Dong T, Li W, Wei X.
    Tumour Biol; 2014 May 01; 35(5):4411-7. PubMed ID: 24408016
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001 May 01; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 19. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
    Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, Dranoff G.
    Cancer Res; 2000 Jun 15; 60(12):3239-46. PubMed ID: 10866317
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
    Kayaga J, Souberbielle BE, Sheikh N, Morrow WJ, Scott-Taylor T, Vile R, Chong H, Dalgleish AG.
    Gene Ther; 1999 Aug 15; 6(8):1475-81. PubMed ID: 10467372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.